Steve Everett

Company: MaveriX Oncology

Job title: Chief Executive Officer

Seminars:

Highlighting Emerging Linker Technologies That Optimize Payload Release & Clearance to Improve Safety Profiles 12:00 pm

How can we engineer linkers to control payload clearance and mitigate toxicity? – Understanding how modifying linker chemistry can influence payload retention and off-target effects Targeting linker cleavage mechanisms for precision payload release – how tumor-specific protease linkers can help reduce systemic exposure, and why protease expression in normal tissues complicates ADC safety Exploring linker…Read more

day: Scientific Program Day Two